Automated quantitative determination of a new polyamine biosynthesis inhibitor (CGP 48 664) and a potential metabolite in human and animal plasma by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 681, Issue 2, 1996, Pages 339-345

  Degen, P H ^a   Zbinden, P ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

2 (4 carbamoyl 2,3 dihydro 1H inden 1 yliden) hydrazine carboximidamide; 4 amidino 1 indanone 2' amidinohydrazone

Indexed keywords

4 AMIDINO 1 INDANONE 2' AMIDINOHYDRAZONE; CGP 53391; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOMATION; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0029974939     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(96)00026-6     Document Type: Article

References (1)

1. D. Fan, U. Regenass, H. Kaufmann, M. Gutman, P.J. Beltran, T.E. Campbell, Y.F. Wang, D. Bielenberg and I.J. Fidler, Ann. Oncol., 52 (1994) 81.